Ignite Creation Date:
2025-12-24 @ 2:55 PM
Ignite Modification Date:
2026-01-25 @ 4:35 PM
Study NCT ID:
NCT04666259
Status:
COMPLETED
Last Update Posted:
2025-10-16
First Post:
2020-12-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Asciminib in Monotherapy for Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With and Without T315I Mutation
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-25
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06-26
Completion Date Type:
ACTUAL
First Submit Date:
2020-12-07
First Submit QC Date:
None
Study First Post Date:
2020-12-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-06-14
Results First Submit QC Date:
None
Results First Post Date:
2024-07-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-08
Last Update Post Date:
2025-10-16
Last Update Post Date Type:
ESTIMATED